¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü) : 2023-10-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü) : 2023-10-28
±³À°ÀÏÀÚ : 2023-10-28
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ

±³À°ÁÖÁ¦ : Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü)

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹Æ÷µµ¸·ÇÐȸ

´ã´çÀÚ : Á¶À翵
¿¬¶ôó : 02-6403-4300

À̸ÞÀÏ : jyjomtl@naver.com

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ï : Á¤È¸¿ø Àü¹®ÀÇ (¹«·á) / ºñȸ¿ø Àü¹®ÀÇ 30,000¿ø / Àü°øÀÇ µî ¹«·áÇöÀåµî·Ï : Á¤È¸¿ø Àü¹®ÀÇ 40,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 40,000¿ø / Àü°øÀÇ 30,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 08:50~09:00 °³È¸»ç ¹× Àλ縻¾¸ ÇÔµ·ÀÏ ÀÌÇü±Ù ȸÀå(Çѱ¹Æ÷µµ¸·ÇÐȸ ¹× Çѱ¹°¢¸·ÇÐȸ)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:00~09:20 Role of ACAID in anterior segment inflammation ÃÖ¹®Á¤(Àϻ꺴¿ø)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:20~09:40 Metagenomics in uveitis ÀÌÁØ¿ø(¿¬¼¼´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 09:40~10:00 Neuro-immune crosstalk in the corneal inflammation ÃÖ¿µÁØ(¾ÆÁÖ´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:00~10:20 AI in uveitis Á¶¹üÁÖ(ÇѸ²´ë)

ÈÞ½Ä 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:20~10:35 ÈÞ½Ä -(-)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:35~10:55 Anterior scleritis ±è¼±¿õ(¿¬¼¼´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 10:55~11:15 Posterior scleritis ¿ì¼¼ÁØ(¼­¿ï´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:15~11:35 Management of anterior segment inflammation associated with autoimmune disorders ÀÌÇö¼ö(°¡Å縯´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:35~11:55 Management of posterior segment inflammation associated with autoimmune disorders ¹Ú¼ºÈÄ(ºÎ»ê´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 11:55~12:25 Clinical/basic approaches to corneal endotheliitis Dai Miyazaki(Tottori University)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 12:25~12:55 Ophthalmic Characteristics of Behçet Disease Radgonde Amer(Hadassah Medical Center)

Åä·Ð 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 12:55~13:10 ÅäÀÇ -(-)

½Ä»ç 10¿ù 28ÀÏ 13:10~14:10 Á¡½É -(-)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:10~14:30 Guidelines for the use of systemic immunosuppressants in ocular inflammatory diseases ¿ÀÁÖ¿¬(¼­¿ï´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:30~14:50 CMV PCR in anterior uveitis; is it a necessity? ÀÌ°æ¹Î(°¡Å縯°üµ¿´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 14:50~15:10 Herpes simplex virus vs varicella zoster virus : similar but different ±èµ¿Çö(°í·Á´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:10~15:30 Ocular inflammation associated with targeted chemotherapy ±èÀ±Àü(¿ï»ê´ë)

ÈÞ½Ä 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:30~15:40 ÈÞ½Ä -(-)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:40~15:50 Human breast milk-derived exosomes ameliorate the ocular surface inflammation in a rabbit dry eye model Áö¿ë¿ì(¿¬¼¼´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 15:50~16:00 Paradoxical Duo of M1 and M2 Macrophages in Pterygium Lymphangiogenesis ±è°æ¿ì(Áß¾Ó´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:00~16:10 Transient corneal edema after successful DMEK with satisfactory postoperative visual acuity: What happens in clear DMEK graft? ÀÌÈÆ(¿ï»ê´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:10~16:20 Serial changes in the aqueous IL-10 level as an indicator of primary vitreoretinal lymphoma recurrence; a single tertiary center experience ¹Ú¿µ±Ù(°¡Å縯´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:20~16:30 Secondary retinal vasoproliferative tumor in a patient with retinitis pigmentosa ±èÀº¾Æ(ÀÎÁ¦´ë)

±³À°½Ã°£ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:30~16:40 Clinical characteristics of patients with Possner-Schlossman syndrome ±è¹ÎÈ£(¾Ð±¸Á¤¼º¸ð¾È°ú)

±âŸ 10¿ù 28ÀÏ ¸¶¸®¾ÆȦ 16:40~16:45 Æóȸ»ç ±è¼±¿õ(¿¬¼¼´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦2ȸ ¾È¿°Áõ ½ÉÆ÷Áö¾ö (Çѱ¹°¢¸·ÇÐȸ Çѱ¹Æ÷µµ¸·ÇÐȸ °øµ¿ÁÖ°ü) : 2023-10-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŻý¾ÆÇÐȸ Á¦30Â÷ Ãß°èÇмú´ëȸ : 2023-10-28
´ÙÀ½±Û ´ëÇѳ»ºÐºñÇÐȸ SICEM 2023 (The 11th Seoul International Congress of Endocrinology and Metabolism in conjunction with the 42nd Annual Scientific Meeting of Korean Endocrine Society) (2ÀÏÂ÷) : 2023-10-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 75 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 55 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 45 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 46 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷